Stock futures climbed on Wednesday, driven by strong performances from Salesforce and Marvell Technology, following upbeat quarterly earnings. Futures tied to the Dow Jones Industrial Average rose by 215 points…
admin
-
-
President-elect Donald Trump this week transferred his entire stake of shares in Trump Media to a revocable trust of which he is the sole beneficiary, regulatory filings revealed Thursday evening. Trump did not receive any money for the…
-
OpenAI’s “12 Days of Shipmas,” which wrapped up on Friday, brought a sense of levity to end the year. The marketing blitz served as a way for the high-profile and…
-
Love Starbucks holiday drinks? This week, you may not get them. Starbucks Workers United announced baristas will strike starting Friday in three key markets — Seattle, Los Angeles and Chicago. …
-
Party City on Friday announced it will close all of its stores and has initiated corporate layoffs effective immediately, according to a CNN report. CEO Barry Litwin told corporate employees in…
-
The Consumer Financial Protection Bureau is suing America’s three largest banks, accusing the institutions of failing to protect customers from fraud on Zelle, the payment platform they co-own. According to…
-
Uncertainty in the stock market makes it difficult to make investment decisions. When investors sell off stocks, everyone follows without giving it much thought and you’re left trying to figure…
-
The Yield Curve The RRG above shows the rotations of the various maturities on the US-Yield Curve. What we see at the moment is that the shorter maturities like BIL,…
-
When running my StockCharts Technical Rank (SCTR) scan on Thursday, I was a little surprised to find that 75 exchange-traded funds (ETFs) and large-cap stocks made the cut, especially after…
-
Investing
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis
by adminCardiol Therapeutics President and CEO, David Elsley PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics President and CEO, David Elsley, who discusses the company’s lead oral…